Aklog Lishan

Insider Reports History

Location
New York, NY
Signature
/s/ Michael A. Gordon, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Aklog Lishan:

Form 4 holding Chairman and CEO, Director

PAVmed Inc.

Security class
Common Stock
Shares / value
357,614
Estimated value
$78,961
Report date
02 Apr 2026
Price
$0.2208
Ownership
Direct
Form 4 holding Chairman and CEO, Director

PAVmed Inc.

Security class
Common Stock
Shares / value
9,904
Estimated value
$2,186
Report date
02 Apr 2026
Price
$0.2208
Ownership
By Pavilion Venture Partners LLC
Form 4 holding Chairman and CEO, Director

PAVmed Inc.

Security class
Common Stock
Shares / value
45
Estimated value
$9
Report date
02 Apr 2026
Price
$0.2208
Ownership
By HCFP/AG LLC
Form 4 holding Chairman and CEO, Director

PAVmed Inc.

Security class
Common Stock
Shares / value
5
Estimated value
$1
Report date
02 Apr 2026
Price
$0.2208
Ownership
By daughter
Form 4 holding Chairman and CEO, Director

PAVmed Inc.

Security class
Common Stock
Shares / value
5
Estimated value
$1
Report date
02 Apr 2026
Price
$0.2208
Ownership
By son
Form 4 holding Director

CONTRAFECT Corp

Security class
Options (Right to Buy)
Shares / value
42,000
Estimated value
Report date
17 May 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Aklog Lishan

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .